Expression of interest: Prosperity partnerships: advanced therapies safety and toxicity
Opportunity status: Open
Funders: Medical Research Council (MRC)
Funding type: Grant
Total fund: £10,500,000
Award range: £2,000,000 - £4,000,000
Publication date: 30 August 2024
Opening date: 30 August 2024 9:00am UK time
Closing date: 6 November 2024 4:00pm UK time
Apply for funding to support emerging or established research partnerships between businesses and academic partners (lead must be UK-based).
Co-developed programmes should enhance knowledge of the safety and toxicity of advanced therapies, developing tools and resources to assess and mitigate safety risks. The research will integrate discovery and translational science, aiming to propel future advanced therapies into clinics.
Where justified, multiple partners can participate on either side of the partnership, with MRC funding academic costs of £2 million to £4 million FEC for up to five years. Equal contribution is expected by the business partner(s).
Timeline
30 August 2024 9:00am
Expression of interest opening date
10 October 2024
Webinar
6 November 2024 4:00pm
Expression of interest closing date
27 November 2024 9:00am
Full application opening date
12 February 2025 4:00pm
Full application closing date
March 2025
Shortlisting meeting
28 or 29 April 2025
Funding decision meeting (interviews)
To find out more